Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2026-01-25 @ 3:29 PM
Study NCT ID:
NCT01018368
Status:
COMPLETED
Last Update Posted:
2010-05-10
First Post:
2009-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of VX-770 and Rifampin in Healthy Male Subjects
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cystic Fibrosis | View |
Keywords: